Profit Or Loss [Abstract]

Sopharma AD - Filing #6022421

Concept 2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
Profit or loss [abstract]
Profit (loss) [abstract]
Revenue
1 875 304 BGN
1 663 016 BGN
Cost of sales
1 376 508 BGN
1 214 333 BGN
Profit (loss) from operating activities
98 110 BGN
87 881 BGN
Finance income
4 406 BGN
3 304 BGN
Finance costs
13 901 BGN
9 417 BGN
Share of profit (loss) of associates and joint ventures accounted for using equity method
24 473 BGN
22 635 BGN
Profit (loss) before tax
111 198 BGN
85 076 BGN
Tax expense (income)
11 324 BGN
8 743 BGN
Profit (loss)
99 874 BGN
3 897 BGN
95 977 BGN
95 977 BGN
71 121 BGN
76 333 BGN
71 121 BGN
5 212 BGN
Profit (loss), attributable to [abstract]
Profit (loss), attributable to owners of parent
95 977 BGN
71 121 BGN
Profit (loss), attributable to non-controlling interests
3 897 BGN
5 212 BGN
Earnings per share [text block]
Earnings per share [abstract]
Earnings per share [line items]
Basic earnings per share [abstract]
Basic earnings (loss) per share
0.7300
0.5900
Diluted earnings per share [abstract]
Diluted earnings (loss) per share
0.6900
0.5700

Talk to a Data Expert

Have a question? We'll get back to you promptly.